Medicines A-Z
Back to Bonviva Tablet

Bonviva Uses in Pakistan

Bonviva (Ibandronate Sodium) is a bisphosphonate medicine commonly prescribed in Pakistan for bone health. This guide covers all its approved uses, indications, and other important information you should know.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Bonviva (Ibandronate Sodium) is used to treat osteoporosis in postmenopausal women, reduce the risk of bone fractures, and manage bone complications linked to certain cancers. It belongs to the Bisphosphonate class and is available in Pakistan. Always take it at the correct dose as directed by your doctor or pharmacist.

Primary Uses at a Glance

Osteoporosis in postmenopausal women

Bonviva (Ibandronate Sodium) is used for treating osteoporosis, a condition where bones become weak and fragile. This is one of the primary approved indications for Ibandronate Sodium in Pakistan.

As prescribed by your doctor. Standard adult dose: one 150mg tablet once a month.

Reducing fracture risk in postmenopausal osteoporosis

Bonviva (Ibandronate Sodium) is used for lowering the risk of fractures, particularly of the spine, in women with postmenopausal osteoporosis. This is one of the primary approved indications for Ibandronate Sodium in Pakistan.

As prescribed by your doctor. Standard adult dose: one 150mg tablet once a month.

Managing cancer-related bone complications

Bonviva (Ibandronate Sodium) is used for managing bone damage and controlling elevated blood calcium levels that can occur with certain cancers, under specialist supervision. This is one of the primary approved indications for Ibandronate Sodium in Pakistan.

As prescribed by your oncologist or doctor. Dose and form (tablet or injection) depend on the condition.

Other Uses

  • Supporting bone density maintenance in high fracture-risk patients under specialist care

Bonviva Uses (Fayde / Kis kaam aati hai)

Bonviva contains Ibandronate Sodium and belongs to the Bisphosphonate group. Below are all the approved and common uses of Bonviva in Pakistan.

Primary Uses (Mukhya Istemal)

  • Treatment of osteoporosis in postmenopausal women
  • Reducing the risk of bone fractures in postmenopausal osteoporosis
  • Managing bone damage and high blood calcium linked to certain cancers

Who Should Take It (Kin logon ke liye)

  • Postmenopausal women diagnosed with osteoporosis by a doctor
  • Patients identified as having a higher risk of fragility fractures
  • Patients under oncology care for cancer-related bone complications, as directed by a specialist

When NOT to Use Bonviva (Kab nahi leni chahiye)

  • If you are allergic to Ibandronate Sodium or any of its ingredients
  • If you have low blood calcium levels (hypocalcemia) that has not been corrected
  • If you have severe kidney impairment or an esophageal abnormality that delays emptying, or cannot stay upright for at least 60 minutes after dosing

Summary

Bonviva is prescribed for osteoporosis in postmenopausal women, reducing fracture risk, and managing cancer-related bone complications. Always consult a doctor before starting or stopping this medicine.

The information in this guide is for educational purposes only.

Frequently Asked Questions

For which conditions is Bonviva most effective?

Bonviva (Ibandronate Sodium) is most effective for postmenopausal osteoporosis, fracture-risk reduction, and cancer-related bone complications. Always take it for the condition your doctor has prescribed it for.

Can Bonviva be taken without a doctor's prescription?

Bonviva is a prescription medicine. Do not take it without a doctor's advice.

How long does Bonviva take to show results?

Bone density improvements from Bonviva are typically assessed over months, not days, using periodic bone density scans. Follow your doctor's advice on how long to continue the course.

Can Bonviva be taken long-term?

Long-term use of Bonviva should only be done under medical supervision. Your doctor will decide the appropriate duration based on your bone density results and overall risk profile.

What should I do if Bonviva does not seem to work?

If you feel Bonviva is not working after the prescribed course, do not increase the dose on your own. Consult your doctor to review your bone density results and treatment plan.

Sources

  1. DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  3. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.